Ethical Compliance
SUVEN LIFE SCIENCES
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
small
Revenue
63.9%
Debt
0.2%
Liquidity
57.6%
Revenue
Debt
Liquidity
63.9%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Other Income | ₹0.16 |
| Research and Development services | ₹11.69 |
Questionable
INR Crores
| Profit on Investments | ₹4.55 |
Non Compliant
INR Crores
| Interest income | ₹16.43 |
INR Crores
| Revenue from Questionable Sources: | ₹4.55 |
| Revenue from Non Compliant Sources: | ₹16.43 |
| Total: | ₹20.97 |
| Total Revenue: | ₹32.82 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹20.97
₹32.82
= 63.9%
non-compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.